C

Corbus Pharmaceuticals Holdings
D

CRBP

12.960
USD
-0.37
(-2.78%)
مغلق
حجم التداول
27,399
الربح لكل سهم
-4
العائد الربحي
-
P/E
-3
حجم السوق
157,846,087
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACAD
    0.140
    (0.84%)
    16.880 USD
    A
    AKTX
    0.00500
    (0.50%)
    1.00000 USD
    C
    CARA
    0.01330
    (3.25%)
    0.42260 USD
    C
    CRSP
    0.360
    (0.89%)
    40.720 USD
    M
    MRNS
    -0.00120
    (-0.50%)
    0.23870 USD
    T
    TLRY
    0.09000
    (7.79%)
    1.24500 USD
    Z
    ZYNE
    0
    (0%)
    0.000000 USD
    المزيد
الأخبار

العنوان: Corbus Pharmaceuticals Holdings

القطاع: Healthcare
الصناعة: Biotechnology
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.